Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04.
Greg Yothers
No relevant relationships to disclose
Patricia A. Ganz
No relevant relationships to disclose
Samia H. Lopa
No relevant relationships to disclose
Clifford Y. Ko
No relevant relationships to disclose
D. Lawrence Wickerham
No relevant relationships to disclose
Norman Wolmark
Consultant or Advisory Role - Sanofi (U)